Status | Study |
Recruiting |
Study Name: GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome Condition: Epilepsy Dravet Syndrome Date: 2014-08-21 Interventions: Drug: GWP42003-P Other Names: |
Enrolling by invitation |
Study Name: An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes Condition: Epilepsy Dravet Syndrome Lennox-Gastaut Syndrome Date: 2014-08-21 Interventions: Drug: GWP42003-P Other Names: Cannabidiol CBD |
Terminated |
Study Name: Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome Condition: Dravet Syndrome Date: 2014-07-09 Interventions: Drug: Clobazam Other Name: Onfi® |
Withdrawn |
Study Name: Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome Condition: Dravet Syndrome Date: 2014-06-02 Interventions: Drug: Clobazam Other Name: Onf |
Completed |
Study Name: Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) Condition: Epilepsy Dravet Syndrome Date: 2014-03-17 Interventions: Drug: GWP42003-P GWP42003-P is |
Completed |
Study Name: A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1) Condition: Epilepsy Dravet Syndrome Date: 2014-03-17 Interventions: Drug: GWP42003-P |
Available |
Study Name: Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome Condition: Dravet Syndrome Date: 2013-11-07 Interventions: Drug: Stiripentol |
Available |
Study Name: Compassionate Use of Stiripentol in Dravet Syndrome Condition: Dravet Syndrome Date: 2013-04-15 Interventions: Drug: Stiripentol Stiripentol 5-50mg/kg/d divided twice or three times a day by mouth |
Completed |
Study Name: Verapamil as Therapy for Children and Young Adults With Dravet Syndrome Condition: Dravet Syndrome Date: 2012-05-24 Interventions: Drug: Verapamil Verapamil will be prepared as a solution. |
No longer available |
Study Name: Stiripentol in Dravet Syndrome Condition: Dravet Syndrome Date: 2012-02-09 Interventions: Drug: stiripentol Stiripentol up to 30 mg/kg/day to control seizures |